Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer

Heyang Zhang(Academy of Military Medical Sciences), Hanping Shi(Beijing Shijitan Hospital), Guo‐Tian Ruan(Beijing Friendship Hospital), Shiqi Lin(Nanjing University of Information Science and Technology), Hongxia Xu(Kunming University of Science and Technology), Hailun Xie(Guangxi Medical University), Chunhua Song(Zhengzhou University), Mengmeng Song(China Pharmaceutical University), Qi Zhang(Jiamusi University), Xiaoyue Liu(Zhejiang University), Xiaowei Zhang(Shanghai Medical College of Fudan University), Ming Yang(Jiangsu University), Yi‐Zhong Ge(China International Science and Technology Cooperation), Meng Tang(Capital Medical University)
BMC Cancer
October 20, 2022
Cited by 19


Related Papers